| Poster Name | Congress | Location | Year |
|---|---|---|---|
| Comparison of nonmotor effects of subcutaneous apomorphine infusion and intrajejunal levodopa infusion | EFNS | Budapest | 2011 |
| A multicenter European comparative survery of motor and nonmotor effects of Apo and Levodopa infusion in PD | MDS | Dublin | 2012 |
| A multicentre European comparative case control study of apo versus levodopa in advanced PD | MDS | Sydney | 2013 |
| A multicentre European survery of advanced therapies in PD | MDS | Berlin | 2016 |
| Effect of acute nonoral dopaminergic treatment on NMS PD | MDS | San Diego | 2015 |
| Poster Name | Congress | Location | Year |
|---|---|---|---|
| Dopamine transporter uptake, daytime sleepiness and fatigue in Parkinson’s disease exploring the role of striatal dopaminergic denervation | MDS | Dublin | 2012 |
| NMS in PD and putamen DaTsCAN update | MDS | Vancouver | 2017 |
| Olfactory dysfunction in PD and DaTScan update | NMDPD | Ljubljana | 2016 |
| Gastrointestinal symptoms in PD and striatal DaTScan update | NMDPD | Ljubljana | 2016 |
| Does cognitive impairment in PD correlate with DaTScan uptake | WPC | Portland Oregon | 2016 |
| DaTScan, clinical impression of severity index and cognitive impairment in PD | MDS | San Diego | 2015 |
| Poster Name | Congress | Location | Year |
|---|---|---|---|
| RLS in early and advanced PD a prospective observational analysis and correlation with other nonmotor features | MDS | Dublin | 2012 |
| Poster Name | Congress | Location | Year |
|---|---|---|---|
| Bilateral subthalamic stimulation improves aspects of nonmotor symptoms in PD | MDS | Stockholm | 2014 |
| Exploratory analysis on the effect of bilateral subthalamic nucleus DBS on fatigue in PD | KCL | London | 2019 |
| NM outcomes of subthalamic stimulation in PD depending on location of active contacts | Safra | London | 2017 |
| Subthalamic stimulation lead coordinates correlate with the nonmotor effects in PD | MDS | San Diego | 2015 |
| Early subthalamic neurostimulation improves qualit of life of elderly patients with PD | MDS | San Diego | 2015 |
| Poster Name | Congress | Location | Year |
|---|---|---|---|
| The use of NMSQuest score to address PD nonmotor burden in outpatient clinic | ENS | Istanbul | 2014 |
| Assessing the nonmotor symptoms burden progression in a longitudinal study of PD patients using NMSQuest | WPC | Sydney | 2015 |
| The international MDS-NMS for PD preliminary results from an international validation | MDS | Hong Kong | 2018 |
| MDS-NMS Scale, results from the initial phases of an international validation | MDS | Berlin | 2016 |
| A global survery of linguistic validations of the NMSQuest and NMSS | MDS | Vancouver | 2017 |
| Clinical correlation of severe somnolence in PD | MDS | Vancouver | 2017 |
| Motor and NM Biomarkers in de novo PD preliminary data from the Kassel-Kings-Madrid Cohort study | MDS | Vancouver | 2017 |
| Assessing the convergent validity of two measures of NMS in PD | NMDPD | Ljubljana | 2016 |
| Assessment of NMS in Turkish patients with PD using NMSQuest | NMDPD | Ljubljana | 2016 |
| Poster Name | Congress | Location | Year |
|---|---|---|---|
| The clinical implications of using 123I-mIBG and the predictive role in Clinically Unclear Parkinsonian Syndromes (CUPS) a naturalistic Follow up study | WPC | Portland Oregon | 2013 |
| Poster Name | Congress | Location | Year |
|---|---|---|---|
| Multicenter report of clinical use of a nonmotor questionnaire for craniocervical dystonia the DNMS Quest | MDS | Berlin | 2016 |
| The development of nonmotor questionnaire for craniocervical dystonia | MDS | Toronto | 2011 |
| Evaluation of the use of Dystonia NMS Questionnaire for craniocervical dystonia in outpatient clinic | MDS | Stockholm | 2014 |
| Poster Name | Congress | Location | Year |
|---|---|---|---|
| Nonmotor fluctuations in PD assessment in clinic | MDS | Stockholm | 2014 |
| Poster Name | Congress | Location | Year |
|---|---|---|---|
| Nonmotor subtyping based on burden of NMS in PD first analysis from an international naturalistic study | MDS | Vancouver | 2017 |
| Advanced or complex PD a prospective study of PD greater than 15 years | MDS JP200 | London | 2017 |
| Clinical Characteristics of Park Sleep in PD Subtype | MDS JP200 | London | 2017 |
| NMS Bruden and motor staging of PD, evidence for dichotomy and NM dominant subtypes | MDS | Berlin | 2016 |
| Self-rated NMS burden grading identifies landmarks and NM Subtypes of PD | MDS | Vancouver | 2017 |
| Poster Name | Congress | Location | Year |
|---|---|---|---|
| Apomorphine infusion and amyloid deposition in PD, preliminary clinical and amyloid imaging data | KCL | London | 2019 |
| Continous apomorphine infusion and cognition in PD | NMDPD | Ljubljana | 2016 |
| Poster Name | Congress | Location | Year |
|---|---|---|---|
| The use of wearable sensors in management of motor symptoms in Parkinson’s Disease: a real-life study | MDS | Nice | 2019 |
| Wearable technology in PD design of the PKG | KCL | London | 2019 |
| Wearable sensors (PKG) and DaTScan imaging as a potential biosignature for constipation in PD | KCL | London | 2019 |
| Remote and personalised monitoring of motor and NMS of PD | Safra | London | 2017 |
| PKG Sleep Assessment | MDS | San Diego | 2015 |
The International Parkinson’s Centre of Excellence in Parkinson’s/ Movement Disorders group mainly focuses on high quality clinical and translational work addressing non motor aspects of Parkinson’s disease (PD) regarded and listed as a key unmet need by NICE.
© 2024 Parkinson's London.